Daniel Ives is the founder of Shift Bioscience, a longevity biotech company that targeting aging from mitochondrial DNA dysfunction and epigenetic screens.
Daniel Ives is the founder of Shift Bioscience, a longevity biotech company that targeting aging from mitochondrial DNA dysfunction and epigenetic screens.